| James O Nell, CRNA | |
|
1001 S George St, York, PA 17403-3676 | |
| (717) 812-7687 | |
| Not Available |
| Full Name | James O Nell |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 18 Years |
| Location | 1001 S George St, York, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013088632 | NPI | - | NPPES |
| 1018996770002 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN523009L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| York Hospital | York, PA | Hospital |
| Wellspan Surgery And Rehabilitation Hospital | York, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellspan Medical Group | 1951213115 | 1946 |
News Archive
Brain imaging can offer a window into risk for diseases such as Alzheimer's disease (AD). A study conducted at the University of Kansas School of Medicine demonstrated that genetic risk is expressed in the brains of even those who are healthy, but carry some risk for AD. The results of this study are published in the November 2009 issue of the Journal of Alzheimer's Disease.
The U.S. Food and Drug Administration approved Xgeva (denosumab) on Thursday to help prevent skeletal-related events (SREs) in patients with cancer that has spread (metastasized) and damaged the bone. Skeletal-related events include bone fractures from cancer and bone pain requiring radiation.
Sedentary, obese older adults appear to improve their functional abilities and reduce insulin resistance through a combination of resistance and aerobic exercises, according to a report in the January 26 issue of Archives of Internal Medicine.
Pfizer Inc. and Cellectis today announced that they have entered into a global strategic collaboration to develop Chimeric Antigen Receptor T-cell (CAR-T) immunotherapies in the field of oncology directed at select targets.
› Verified 6 days ago
| Entity Name | Anesthesia Associates Of York Pa Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205812260 PECOS PAC ID: 2769394949 Enrollment ID: O20031105000332 |
News Archive
Brain imaging can offer a window into risk for diseases such as Alzheimer's disease (AD). A study conducted at the University of Kansas School of Medicine demonstrated that genetic risk is expressed in the brains of even those who are healthy, but carry some risk for AD. The results of this study are published in the November 2009 issue of the Journal of Alzheimer's Disease.
The U.S. Food and Drug Administration approved Xgeva (denosumab) on Thursday to help prevent skeletal-related events (SREs) in patients with cancer that has spread (metastasized) and damaged the bone. Skeletal-related events include bone fractures from cancer and bone pain requiring radiation.
Sedentary, obese older adults appear to improve their functional abilities and reduce insulin resistance through a combination of resistance and aerobic exercises, according to a report in the January 26 issue of Archives of Internal Medicine.
Pfizer Inc. and Cellectis today announced that they have entered into a global strategic collaboration to develop Chimeric Antigen Receptor T-cell (CAR-T) immunotherapies in the field of oncology directed at select targets.
› Verified 6 days ago
| Entity Name | Lebanon Anesthesia Associates Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407844079 PECOS PAC ID: 4688570997 Enrollment ID: O20031209000210 |
News Archive
Brain imaging can offer a window into risk for diseases such as Alzheimer's disease (AD). A study conducted at the University of Kansas School of Medicine demonstrated that genetic risk is expressed in the brains of even those who are healthy, but carry some risk for AD. The results of this study are published in the November 2009 issue of the Journal of Alzheimer's Disease.
The U.S. Food and Drug Administration approved Xgeva (denosumab) on Thursday to help prevent skeletal-related events (SREs) in patients with cancer that has spread (metastasized) and damaged the bone. Skeletal-related events include bone fractures from cancer and bone pain requiring radiation.
Sedentary, obese older adults appear to improve their functional abilities and reduce insulin resistance through a combination of resistance and aerobic exercises, according to a report in the January 26 issue of Archives of Internal Medicine.
Pfizer Inc. and Cellectis today announced that they have entered into a global strategic collaboration to develop Chimeric Antigen Receptor T-cell (CAR-T) immunotherapies in the field of oncology directed at select targets.
› Verified 6 days ago
| Entity Name | Wellspan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
Brain imaging can offer a window into risk for diseases such as Alzheimer's disease (AD). A study conducted at the University of Kansas School of Medicine demonstrated that genetic risk is expressed in the brains of even those who are healthy, but carry some risk for AD. The results of this study are published in the November 2009 issue of the Journal of Alzheimer's Disease.
The U.S. Food and Drug Administration approved Xgeva (denosumab) on Thursday to help prevent skeletal-related events (SREs) in patients with cancer that has spread (metastasized) and damaged the bone. Skeletal-related events include bone fractures from cancer and bone pain requiring radiation.
Sedentary, obese older adults appear to improve their functional abilities and reduce insulin resistance through a combination of resistance and aerobic exercises, according to a report in the January 26 issue of Archives of Internal Medicine.
Pfizer Inc. and Cellectis today announced that they have entered into a global strategic collaboration to develop Chimeric Antigen Receptor T-cell (CAR-T) immunotherapies in the field of oncology directed at select targets.
› Verified 6 days ago
| Entity Name | Enteron, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750330783 PECOS PAC ID: 6507833506 Enrollment ID: O20040910000219 |
News Archive
Brain imaging can offer a window into risk for diseases such as Alzheimer's disease (AD). A study conducted at the University of Kansas School of Medicine demonstrated that genetic risk is expressed in the brains of even those who are healthy, but carry some risk for AD. The results of this study are published in the November 2009 issue of the Journal of Alzheimer's Disease.
The U.S. Food and Drug Administration approved Xgeva (denosumab) on Thursday to help prevent skeletal-related events (SREs) in patients with cancer that has spread (metastasized) and damaged the bone. Skeletal-related events include bone fractures from cancer and bone pain requiring radiation.
Sedentary, obese older adults appear to improve their functional abilities and reduce insulin resistance through a combination of resistance and aerobic exercises, according to a report in the January 26 issue of Archives of Internal Medicine.
Pfizer Inc. and Cellectis today announced that they have entered into a global strategic collaboration to develop Chimeric Antigen Receptor T-cell (CAR-T) immunotherapies in the field of oncology directed at select targets.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James O Nell, CRNA 3421 Concord Rd, York, PA 17402-9001 Ph: (717) 812-7687 | James O Nell, CRNA 1001 S George St, York, PA 17403-3676 Ph: (717) 812-7687 |
News Archive
Brain imaging can offer a window into risk for diseases such as Alzheimer's disease (AD). A study conducted at the University of Kansas School of Medicine demonstrated that genetic risk is expressed in the brains of even those who are healthy, but carry some risk for AD. The results of this study are published in the November 2009 issue of the Journal of Alzheimer's Disease.
The U.S. Food and Drug Administration approved Xgeva (denosumab) on Thursday to help prevent skeletal-related events (SREs) in patients with cancer that has spread (metastasized) and damaged the bone. Skeletal-related events include bone fractures from cancer and bone pain requiring radiation.
Sedentary, obese older adults appear to improve their functional abilities and reduce insulin resistance through a combination of resistance and aerobic exercises, according to a report in the January 26 issue of Archives of Internal Medicine.
Pfizer Inc. and Cellectis today announced that they have entered into a global strategic collaboration to develop Chimeric Antigen Receptor T-cell (CAR-T) immunotherapies in the field of oncology directed at select targets.
› Verified 6 days ago
Adrienne Chakot, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1001 S George St, York, PA 17403 Phone: 717-812-7687 | |
Robert Merritt, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 25 Monument Rd Ste 270, York, PA 17403 Phone: 717-741-8250 Fax: 717-741-8289 | |
Mr. Paul G Hester, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 25 Monument Rd Ste 270, York, PA 17403 Phone: 717-741-8250 Fax: 717-741-8289 | |
Allison Weston, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1001 S George St, York, PA 17403 Phone: 717-812-7687 Fax: 717-851-5250 | |
Deborah L Aumiller, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1001 S George St, York, PA 17403 Phone: 717-812-7687 | |
Linda K Zinkand, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1001 S George St, York, PA 17403 Phone: 717-851-2415 Fax: 717-851-5250 |